Report Highlights
The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019.
Report Includes
- An overview of the global market for breast cancer diagnostics and drug technologies.
- Analyses of market trends, with data from 2012, estimates for 2014, and projections of CAGRs through 2019.
- A comprehensive review of emerging breast cancer personalized and predictive diagnostic tests, particularly with regard to companion tests, tumor markers, and gene profiling assays relevant for breast cancer prognosis and diagnosis.
- Information on products in the market and detailed analyses of the market's segments and competitive environments.
- Assessments of technological developments, product innovations, and recent strategic industry activity of across different product categories.
- Comprehensive company profiles of major players in the industry.
SCOPE AND FORMAT
This report provides an update and overview on predictive testing in breast cancer diagnostics and drug technologies and global markets as well as global incidence rates for breast cancer. The study’s objective is to review tumor marker-based predictive companion tests and drugs for breast cancer, and then assess their global growth potential over a five-year period from 2014 to 2019. The comprehensive review includes global markets for current drugs, new developments, predictive diagnostic tests and new technologies, drugs and developments. The report forecasts market trends forecast trends for the use of current tests for better diagnosis and prognosis of breast cancer through 2019.
Important current diagnostic tests, technologies and developments; market share by drug, test and current products on the market; market share by company or product; and statistical information for types of breast cancer incidence and prevalence globally, with special emphasis on the U.S. market, are discussed. The report focuses on tumor marker-based testing, which provides vital information about the cancer.These tests can help determine the appropriate medicine and timing of treatment to address the disease most effectively. The report also includes information on current issues and trends affecting the industry. The report covers products in development, new technologies, trends, alliances, new developments and patents and mergers. It offers market data with respect to segments and geography. Other breast cancer detection and screening technologies and markets (e.g., mammography, ultrasound, biopsy) are not included in this report
ANALYST’S CREDENTIALS
Usha Nagavarapu is a pharmaceutical professional with experience in scientific and alliance development. This includes more than 10 years of drug and device product development and alliance management experience. She has managed preclinical discovery programs from target identification through design of Phase I testing, including Investigational New Drug (IND) enabling studies, and assisted out-licensing and portfolio development activities. Strong focus areas include oncology, dermatology and cardiovascular diseases. She has extensive experience working with early startups to fulfill operational obligations while minimizing overall operational cost and burden.
Related Reports
Next Generation Cancer Diagnostics: Technologies and Global Markets
BCC Research estimates the global market for next generation cancer diagnostic as $1.6 billion in 2013. This indication is expected to reach $1.8 billion in 2014 and $10 billion in 2019, registering a compound annual growth (CAGR) of 42.6% over the next five years.
Cancer Profiling and Pathways: Technologies and Global Markets
The global market for cancer profiling technologies reached $26.1 billion in 2012. This market is expected to grow to nearly $30.1 billion in 2013 and $54.8 billion in 2018, a compound annual growth rate (CAGR) of 12.8% over the five-year period, 2013 to 2018.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare
The global market for cognitive computing and Artificial Intelligence (AI) systems market in healthcare was valued at $11.4 billion in 2025 and, is estimated to reach $50.1 billion by 2030, at a compound annual growth rate (CAGR) of 34.4% from 2025 through 2030.
State of the Life Sciences Industry - 2026 Second Quarter Review
Discover BCC Research’s Q2 2026 life sciences industry review, highlighting market trends, innovation, sector performance, and growth opportunities.
Cardiovascular Devices: Global Markets to 2030
The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.
Global Healthcare Fraud Detection Market
This report provides a brief general outlook of the global healthcare fraud detection market. It includes global revenue ($ million) for base year data of 2024, estimated data of 2025, and forecasts through 2030. The report focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Global Orthopedic Surgical Robots Market
The global market for orthopedic surgical robots was valued at $2.7 billion in 2025 and is expected to reach $4.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2030.
Top Trending Reports
State of the Life Sciences Industry - 2026 Second Quarter Review
Discover BCC Research’s Q2 2026 life sciences industry review, highlighting market trends, innovation, sector performance, and growth opportunities.
Cardiovascular Devices: Global Markets to 2030
The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.
Global Veterinary Medical Devices Market
This report provides an in-depth analysis of the global veterinary medical devices market by device type, animal type, and region. It examines key market trends, technologies, competitive dynamics, and challenges influencing the industry. Regional analysis covers North America, Europe, Asia-Pacific, the Middle East & Africa, and South America, with a focus on major countries within these regions. The study also includes profiles of leading companies, highlighting financials, product portfolios, and recent developments, along with market forecasts through 2030.
Global HLA Typing for Transplant Market
This report analyzes the global HLA typing for transplant market, covering market size, growth trends, industry dynamics, emerging technologies, and competitive developments. The market is segmented by product and service type, technology, application, end user, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study includes insights into key applications such as solid organ and hematopoietic stem cell transplants, along with profiles of leading companies and forecasts through 2030.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.
Report Highlights
The global market for Predictive Breast Cancer diagnostic and drug Technologies was valued at $23.4 billion in 2010 and came down to $21.2 billion in 2011. This market is expected to rise at a compound annual growth rate (CAGR) of 2.5% and reach $24 billion by 2016.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More